Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:1.14.99.3 (
heme oxygenase
)
4,196
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We previously observed that nitric oxide (NO) exposure increases the stability of mRNAs encoding
heme oxygenase
1 (HO-1) and TIEG-1 in human and mouse fibroblasts. Here, we have used microarrays to look broadly for changes in mRNA stability in response to NO treatment. Using human IMR-90 and mouse NIH 3T3 fibroblasts treated with actinomycin D to block de novo transcription, microarray analysis suggested that the stability of the majority of mRNAs was unaffected. Among the mRNAs that were stabilized by NO treatment, seven transcripts were found in both IMR-90 and NIH 3T3 cells (CHIC2, GADD45B, HO-1, PTGS2, RGS2, TIEG, and ID3) and were chosen for further analysis. All seven mRNAs showed at least one hit of a signature motif for the stabilizing RNA-binding protein (RBP)
HuR
; accordingly, ribonucleoprotein immunoprecipitation analysis revealed that all seven mRNAs associated with
HuR
. In keeping with a functional role of
HuR
in the response to NO, a measurable fraction of
HuR
increased in the cytoplasm following NO treatment. However, among the seven transcripts, only HO-1 mRNA showed a robust increase in the level of its association with
HuR
following NO treatment. In turn, HO-1 mRNA and protein levels were significantly reduced when
HuR
levels were silenced in IMR-90 cells, and they were elevated when
HuR
was overexpressed. In sum, our results indicate that NO stabilizes mRNA subsets in fibroblasts, identify
HuR
as an RBP implicated in the NO response, reveal that
HuR
alone is insufficient for stabilizing several mRNAs by NO, and show that HO-1 induction by NO is regulated by
HuR
.
...
PMID:Analysis of nitric oxide-stabilized mRNAs in human fibroblasts reveals HuR-dependent heme oxygenase 1 upregulation. 1928